Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion type Assertion NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_head.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion description "[EC is known for extensive epigenetic alterations, including overexpression of HDAC and DNMT enzymes, and the frequent epigenetic silencing of DNA repair genes such as MLH1, tumor suppressor genes PTEN, and progesterone receptor, which suggests a potentially high sensitivity of this type of cancer to HDAC inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_provenance.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion evidence source_evidence_literature NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_provenance.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion SIO_000772 23888962 NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_provenance.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion wasDerivedFrom befree-20150227 NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_provenance.
- NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_assertion wasGeneratedBy ECO_0000203 NP357242.RANsY9by6zDgZVmXSYsYP9KWTGU7_2GFl5-qeaqDeoA-0130_provenance.